Cassava Sciences | PTIE - Ebit

Precio De Mercado
1.73
Cambio Diario
-0.03 -1.70%
Mensual
-9.42%
Anual
18.49%
Q2 Expectativa
1.60




Ebit Cambio Fecha
Abbott USD 1.85B 684M 2026-03
Amgen USD 3.96B 464M 2025-12
Biogen USD 659.6M 157M 2025-09
Cara Therapeutics USD -5.94M 3.55M 2025-09
Cassava Sciences USD -13.55M 1.69M 2025-12
Eisai JPY 20.03B 6.36B 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Geron USD -10.79M 3.1M 2025-12
J&J USD 6.62B 1.51B 2026-03
Merck USD 6.24B 1.32B 2025-12
Novartis USD 4.06B 530M 2025-12
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD 4.65B 71M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12